PropelRx
Fundraising readiness platform for Series A and B founders
48 followers
Fundraising readiness platform for Series A and B founders
48 followers
PropelRx is a fundraising readiness platform for Seed to
Series B founders.
Before you approach a single investor, PropelRx assesses
your capital readiness across 8 institutional dimensions
— narrative, financials, materials, and positioning.
You get a Capital Readiness Score and a prioritised fix
list. Execution unlocks only when thresholds are met.
Not a CRM. Not a database. The layer that comes before.
Really thoughtful framing, @jamal_hirani .
The structural alignment point resonates with me strongly.
As a Danish founder who has been through multiple raises, one thing I struggled with early on was understanding whether venture truly operates on the same scoreboard everywhere.
In Scandinavia we often build with a slightly different cultural starting point. Less hype, more consensus, slower storytelling, sometimes more product first than narrative first.
But when you step into the global VC ecosystem, the expectations around timing, narrative clarity, and investor targeting are very specific. If you don’t understand those signals early, you can easily go to market too soon or speak a slightly different language than the funds expect.
So the structural alignment question becomes broader than stage or mandate. It also becomes cultural alignment between founder mindset and venture expectations.
Tools that help founders diagnose readiness before exposure probably save more than time. They protect credibility.
Curious how you think about this:
Is the venture “scoreboard” actually universal today, or do founders still need to learn different venture cultures depending on the ecosystem they come from?
@fatviking Morten — this is a thoughtful articulation of the challenge.
I don’t think the venture “scoreboard” is universal — but the meta-patterns are.
Cultural starting points differ (as you describe in Scandinavia), but once founders enter the global capital market, expectations around timing, signal clarity, and narrative compression tend to converge.
Where I think founders struggle most is assuming product strength alone translates across ecosystems without recalibrating the signalling layer.
Do you feel that founders expanding globally need to consciously “translate” their narrative — or should funds be more adaptive to regional starting points?
Great point @jamal_hirani ...I think founders expanding globally definitely need to learn to “translate” their narrative.
Product strength alone rarely carries the signal across ecosystems.
In Scandinavia we often believe the product should speak for itself. In global venture markets, the narrative is what allows the product to be understood in the first place.
So the challenge becomes learning the signalling layer without losing the cultural strengths that shaped the company in the first place.
The interesting tension is this:
If everyone optimises for the same signalling patterns, do we risk filtering out the very founders who think differently?
Currently raising and can confirm the chaos is real.
The hardest part hasn’t been storytelling — it’s been targeting the right investors without burning intros.
How does PropelRx differentiate between stated thesis and actual deployment behaviour?
@white_devil22 Completely agree — the chaos usually isn’t storytelling, it’s targeting. Burning good introductions with the wrong funds is one of the most expensive mistakes in a raise.
On the thesis vs behaviour point: we try to prioritise observed deployment patterns over stated theses. Many funds describe themselves broadly, but their actual check sizes, stage timing, follow-on patterns and recent portfolio activity tell a much clearer story.
The system looks at things like recent investments, check size ranges, stage distribution and sector exposure to estimate alignment rather than relying purely on how a fund describes itself.
Curious if you've found the same gap between what funds say they invest in and where they actually deploy capital.
Hey Product Hunt 👋
Jamal here — founder of PropelRx.
The idea for PropelRx didn’t come from theory.
It came from watching good founders quietly damage their reputations.
Not because their companies were bad.
But because:
• They went out too early
• Targeted the wrong investors
• Burned intros
• Ran chaotic outreach
• And had no real feedback loop
Fundraising has become performative.
Everyone optimises for activity instead of alignment.
We kept asking a simple question:
What if fundraising was treated like a system — not a scramble?
So we built PropelRx as infrastructure, not just software.
Something that helps founders:
– Diagnose readiness before outreach
– Understand structural investor fit
– Run disciplined campaigns
– Track engagement signal properly
– Avoid credibility burn
The most interesting thing we’ve learned so far:
The biggest fundraising risk isn’t rejection.
It’s premature exposure.
Would genuinely love to hear from this community:
What’s been your hardest moment during a raise?
Was it targeting, timing, narrative, or something else?
We’ll be here all day responding and learning.
– Jamal
"Wanted to give everyone a look under the hood. 🚀
We didn't just build a platform—we’ve built a squad of 4 specialized AI agents to handle the heavy lifting for founders:
🛰️ Atlas — Strategy & Outreach Intelligence: Atlas maps institutional fit and executes disciplined outreach sequences. No more 'cold' emails—it confirms alignment before the first call. 📈
🎙️ Luna — Pitch & Narrative Coach: Luna pressure-tests your narrative through real-time voice sessions. From deck structure to objection handling, she helps eliminate filler and Ensures institutional precision. 💊
📊 AI CFO — Financial Intelligence: The AI CFO transforms raw financials into investor-grade insight. Valuation modeling, unit economics benchmarking, and due diligence prep. 📉
♟️ AIFA — Fundraising Strategist: AIFA is your Chief of Staff. It orchestrates the entire raise—tracking relationships, forecasting close probability, and recommending next actions. It sees the full board so you can make decisive moves. 🚀
The era of the 'solo founder' is over. Scale your raise with the Rx Agent Squad. 💊
We’re live here today to show you exactly how this is changing the game for founders across the globe. 🚀📈"
"Launching today has reminded me how vulnerable fundraising actually is.
Most founders don’t fail because they lack ambition — they fail because they mis-time exposure.
If you’ve raised before:
What was the moment you realised you went too early — or too broad?"
Congrats on the launch! Interesting approach to fundraising. The idea of evaluating investor alignment before outreach makes a lot of sense. Just curious how do you determine the “Capital Readiness Score”? Looking forward to seeing how this evolves.
NotionCircles
This is a really interesting approach to fundraising. Many founders spend months sending cold emails without knowing if investors are actually aligned. Tools like this could save a lot of time. Congrats on the launch! 👏 @jamal_hirani
@inagaraj Appreciate that Nagaraj.
We kept seeing founders burn months sending outreach before understanding whether a fund was structurally aligned with their stage, geography, or check size.
The goal with PropelRx is to diagnose that alignment before the first email goes out.